Skip to main content
OpenTrials

Clinical trial condition

Blood Platelet Disorders

Explore clinical trials studying Blood Platelet Disorders. Study availability and eligibility vary by location and protocol.

957 public trials 209 recruiting studies
Refine in advanced search Browse all conditions

Blood Platelet Disorders trial results

Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00445744

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

NCT00771810

Conditions
Adnexal Diseases, Agranulocytosis, Anemia, +25 more
Locations
  • University of Southern Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • USC - LAC Medical Center Los Angeles, California, United States
  • University of California - Irvine, Chao Family Comprehensive Cancer Center Orange, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

NCT00358540

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +7 more
Locations
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

NCT00903422

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Coral Springs, Florida, United States
View all 65 locations
View Trial Details
Completed

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

NCT00359463

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +10 more
Locations
  • GSK Investigational Site Gainesville, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Randwick, Sydney, New South Wales, Australia
  • GSK Investigational Site Adelaide, South Australia, Australia
View Trial Details

Related conditions